171 related articles for article (PubMed ID: 28990338)
21. (-)-Meptazinol-melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer's therapy.
Cheng S; Zheng W; Gong P; Zhou Q; Xie Q; Yu L; Zhang P; Chen L; Li J; Chen J; Chen H; Chen H
Bioorg Med Chem; 2015 Jul; 23(13):3110-8. PubMed ID: 26025073
[TBL] [Abstract][Full Text] [Related]
22. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.
Joshi P; Chia S; Habchi J; Knowles TP; Dobson CM; Vendruscolo M
ACS Comb Sci; 2016 Mar; 18(3):144-53. PubMed ID: 26923286
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and evaluation of Trolox-conjugated amyloid-β C-terminal peptides for therapeutic intervention in an in vitro model of Alzheimer's disease.
Arai T; Ohno A; Kazunori M; Kakizawa T; Kuwata H; Ozawa T; Shibanuma M; Hara S; Ishida S; Kurihara M; Miyata N; Nakagawa H; Fukuhara K
Bioorg Med Chem; 2016 Sep; 24(18):4138-4143. PubMed ID: 27407032
[TBL] [Abstract][Full Text] [Related]
24. Novel benzylidenephenylpyrrolizinones with pleiotropic activities potentially useful in Alzheimer's disease treatment.
Jourdan JP; Since M; El Kihel L; Lecoutey C; Corvaisier S; Legay R; Sopkova-de Oliveira Santos J; Cresteil T; Malzert-Fréon A; Rochais C; Dallemagne P
Eur J Med Chem; 2016 May; 114():365-79. PubMed ID: 27046230
[TBL] [Abstract][Full Text] [Related]
25. Tools of the trade: investigations into design strategies of small molecules to target components in Alzheimer's disease.
Derrick JS; Lim MH
Chembiochem; 2015 Apr; 16(6):887-98. PubMed ID: 25773481
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of amyloid fibril formation and cytotoxicity by caffeic acid-conjugated amyloid-β C-terminal peptides.
Arai T; Ohno A; Mori K; Kuwata H; Mizuno M; Imai K; Hara S; Shibanuma M; Kurihara M; Miyata N; Nakagawa H; Fukuhara K
Bioorg Med Chem Lett; 2016 Nov; 26(22):5468-5471. PubMed ID: 27789140
[TBL] [Abstract][Full Text] [Related]
27. Medicinal Chemistry Focusing on Aggregation of Amyloid-β.
Sohma Y
Chem Pharm Bull (Tokyo); 2016; 64(1):1-7. PubMed ID: 26726739
[TBL] [Abstract][Full Text] [Related]
28. Ionophoric polyphenols selectively bind Cu(2+), display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila.
Martínez A; Alcendor R; Rahman T; Podgorny M; Sanogo I; McCurdy R
Bioorg Med Chem; 2016 Aug; 24(16):3657-70. PubMed ID: 27316544
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
Li SY; Wang XB; Xie SS; Jiang N; Wang KD; Yao HQ; Sun HB; Kong LY
Eur J Med Chem; 2013 Nov; 69():632-46. PubMed ID: 24095756
[TBL] [Abstract][Full Text] [Related]
30. New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol.
Mao F; Yan J; Li J; Jia X; Miao H; Sun Y; Huang L; Li X
Org Biomol Chem; 2014 Aug; 12(31):5936-44. PubMed ID: 24986600
[TBL] [Abstract][Full Text] [Related]
31. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-β aggregation.
Choi JS; Braymer JJ; Park SK; Mustafa S; Chae J; Lim MH
Metallomics; 2011 Mar; 3(3):284-91. PubMed ID: 21210061
[TBL] [Abstract][Full Text] [Related]
33. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
Savelieff MG; Lee S; Liu Y; Lim MH
ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
[TBL] [Abstract][Full Text] [Related]
34. Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-β metal dyshomeostasis.
Kawada H; Blessing K; Kiyota T; Woolman T; Winchester L; Kador PF
J Alzheimers Dis; 2015; 44(1):297-307. PubMed ID: 25227315
[TBL] [Abstract][Full Text] [Related]
35. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L
Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517
[TBL] [Abstract][Full Text] [Related]
36. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
37. Novel chelators based on adamantane-derived semicarbazones and hydrazones that target multiple hallmarks of Alzheimer's disease.
Palanimuthu D; Wu Z; Jansson PJ; Braidy N; Bernhardt PV; Richardson DR; Kalinowski DS
Dalton Trans; 2018 May; 47(21):7190-7205. PubMed ID: 29749416
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease.
Li SY; Wang XB; Kong LY
Eur J Med Chem; 2014 Jan; 71():36-45. PubMed ID: 24269515
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and characterization of 1H-phenanthro[9,10-d]imidazole derivatives as multifunctional agents for treatment of Alzheimer's disease.
Liu J; Qiu J; Wang M; Wang L; Su L; Gao J; Gu Q; Xu J; Huang SL; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta; 2014 Sep; 1840(9):2886-903. PubMed ID: 24821011
[TBL] [Abstract][Full Text] [Related]
40. Metal Ions and Metal Complexes in Alzheimer's Disease.
Spinello A; Bonsignore R; Barone G; Keppler BK; Terenzi A
Curr Pharm Des; 2016; 22(26):3996-4010. PubMed ID: 27197799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
